HUE049911T2 - Pirrolokinolin-kinon-függõ, oldható glükóz-dehidrogenáz javított mutánsai - Google Patents

Pirrolokinolin-kinon-függõ, oldható glükóz-dehidrogenáz javított mutánsai

Info

Publication number
HUE049911T2
HUE049911T2 HUE17151869A HUE17151869A HUE049911T2 HU E049911 T2 HUE049911 T2 HU E049911T2 HU E17151869 A HUE17151869 A HU E17151869A HU E17151869 A HUE17151869 A HU E17151869A HU E049911 T2 HUE049911 T2 HU E049911T2
Authority
HU
Hungary
Prior art keywords
glucose dehydrogenase
pyrroloquinoline quinone
soluble glucose
dependent soluble
improved mutants
Prior art date
Application number
HUE17151869A
Other languages
English (en)
Hungarian (hu)
Inventor
Mara Boenitz-Dulat
Daniela Beck
Peter Kratzsch
Rainer Schmuck
Der Eltz Herbert Von
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36579921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE049911(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HUE049911T2 publication Critical patent/HUE049911T2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HUE17151869A 2006-04-13 2007-04-11 Pirrolokinolin-kinon-függõ, oldható glükóz-dehidrogenáz javított mutánsai HUE049911T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06007779 2006-04-13

Publications (1)

Publication Number Publication Date
HUE049911T2 true HUE049911T2 (hu) 2020-11-30

Family

ID=36579921

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE17151869A HUE049911T2 (hu) 2006-04-13 2007-04-11 Pirrolokinolin-kinon-függõ, oldható glükóz-dehidrogenáz javított mutánsai
HUE07724148A HUE032804T2 (en) 2006-04-13 2007-04-11 Enhanced mutants of pyrroloquinoline-quinone-dependent soluble glucose dehydrogenase

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE07724148A HUE032804T2 (en) 2006-04-13 2007-04-11 Enhanced mutants of pyrroloquinoline-quinone-dependent soluble glucose dehydrogenase

Country Status (14)

Country Link
US (1) US7732179B2 (enExample)
EP (2) EP2010649B1 (enExample)
JP (3) JP5683809B2 (enExample)
KR (1) KR101168623B1 (enExample)
CN (1) CN101421396B (enExample)
AU (1) AU2007237478B2 (enExample)
BR (1) BRPI0710131B1 (enExample)
CA (1) CA2649135C (enExample)
ES (2) ES2624805T3 (enExample)
HU (2) HUE049911T2 (enExample)
MX (1) MX2008013001A (enExample)
PL (2) PL2010649T3 (enExample)
PT (2) PT2010649T (enExample)
WO (1) WO2007118647A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5753720B2 (ja) * 2010-04-22 2015-07-22 アークレイ株式会社 バイオセンサ
ES2568464T3 (es) 2010-07-23 2016-04-29 F. Hoffmann-La Roche Ag Composiciones que contienen tampón zwiteriónico y usos en dispositivos y métodos electroanalíticos
EP2465936A1 (en) 2010-12-20 2012-06-20 LEK Pharmaceuticals d.d. Enzymatic synthesis of statins and intermediates thereof
CA2822331A1 (en) 2010-12-20 2012-07-19 Lek Pharmaceuticals D.D. Enzymatic synthesis of active pharmaceutical ingredient and intermediates thereof
WO2012084194A1 (en) 2010-12-22 2012-06-28 Roche Diagnostics Gmbh Systems and methods to compensate for sources of error during electrochemical testing
CN102559624B (zh) * 2012-03-05 2013-10-16 浙江德清汇宁生物科技有限公司 一种吡咯喹啉醌依赖型葡萄糖脱氢酶的热稳定性突变体及其高通量筛选方法
JP6111323B2 (ja) 2012-04-19 2017-04-05 エフ ホフマン−ラ ロッシュ アクチェン ゲゼルシャフト 血液中の検体濃度を測定する方法および装置
EP2811299A1 (en) 2013-06-07 2014-12-10 Roche Diagniostics GmbH Test element for detecting at least one analyte in a body fluid
WO2017050872A1 (en) 2015-09-25 2017-03-30 F. Hoffmann-La Roche Ag Transamidation employing sortase a in deep eutectic solvents
JP6895953B2 (ja) 2015-09-25 2021-06-30 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ソルターゼａを利用してチオエステルを作製するための方法
CN105331590B (zh) * 2015-10-29 2020-02-28 英科隆生物技术（杭州）有限公司 葡萄糖特异性改善的可溶性吡咯喹啉醌依赖性葡萄糖脱氢酶突变体、聚核苷酸及其应用
CN111073866B (zh) * 2015-10-29 2024-03-19 英科隆生物技术（杭州）有限公司 PQQ-sGDH突变体、聚核苷酸及其在葡萄糖检测中的应用
KR20180087329A (ko) 2015-12-21 2018-08-01 에프. 호프만-라 로슈 아게 알칼리게네스 파에칼리스로부터의 돌연변이체 3-히드록시부티레이트 탈수소효소 뿐만 아니라 이의 관련 방법 및 용도
WO2017137491A1 (en) 2016-02-09 2017-08-17 Roche Diabetes Care Gmbh Mutant 3-hydroxybutyrate dehydrogenase from rhodobacter sphaeroides as well as methods and uses involving the same
CN109804240A (zh) 2016-10-05 2019-05-24 豪夫迈·罗氏有限公司 用于多分析物诊断测试元件的检测试剂和电极布置以及其使用方法
CN115820608B (zh) * 2022-08-31 2024-06-04 中国海洋大学 λ-卡拉胶酶突变体OUC-CglA-DPQQ及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3716957A1 (de) 1987-05-20 1988-12-01 Boehringer Mannheim Gmbh Expressionsvektor zur regulierbaren expression von fremdgenen in prokaryonten
DE4311464A1 (de) 1993-04-08 1994-10-13 Boehringer Mannheim Gmbh Verfahren zur kolorimetrischen Bestimmung eines Analyten mit einer PQQ-abhängigen Dehydrogenase
DE19639169A1 (de) 1996-09-24 1998-04-02 Boehringer Mannheim Gmbh Redoxaktive Verbindungen und deren Anwendung
JPH10243786A (ja) 1997-03-03 1998-09-14 Koji Hayade 改変型グルコース脱水素酵素
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
JPH11243949A (ja) 1998-03-03 1999-09-14 Toyobo Co Ltd Ｐｑｑを補欠分子族とするグルコースデヒドロゲナーゼおよびその製造方法
WO2000049039A2 (de) * 1999-02-19 2000-08-24 Merck Patent Gmbh Glucose-dehydrogenase-fusionsproteine und ihre verwendung in expressionssystemen
JP2000350588A (ja) * 1999-04-08 2000-12-19 Koji Hayade グルコース脱水素酵素
TWI224136B (en) 1999-04-30 2004-11-21 Koji Sode Glucose dehydrogenase
EP1332216B1 (en) 2000-10-27 2011-08-17 Roche Diagnostics GmbH Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
JP2004344145A (ja) * 2002-05-27 2004-12-09 Toyobo Co Ltd 基質特異性または安定性に優れたピロロキノリンキノン（ｐｑｑ）依存性グルコースデヒドロゲナーゼ改変体
JP2004173538A (ja) 2002-11-25 2004-06-24 Amano Enzyme Inc ピロロキノリンキノン依存性グルコース脱水素酵素
WO2006008132A1 (en) 2004-07-20 2006-01-26 Roche Diagnostics Gmbh Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion

Also Published As

Publication number Publication date
US7732179B2 (en) 2010-06-08
ES2807530T3 (es) 2021-02-23
PL3246402T3 (pl) 2020-10-19
WO2007118647A1 (en) 2007-10-25
EP3246402B1 (en) 2020-05-20
JP2016119904A (ja) 2016-07-07
CA2649135C (en) 2013-11-19
ES2624805T3 (es) 2017-07-17
BRPI0710131A2 (pt) 2011-08-02
MX2008013001A (es) 2008-10-17
AU2007237478B2 (en) 2011-05-19
JP5937547B2 (ja) 2016-06-22
CN101421396A (zh) 2009-04-29
AU2007237478A1 (en) 2007-10-25
EP2010649B1 (en) 2017-03-08
PT2010649T (pt) 2017-05-03
US20090148874A1 (en) 2009-06-11
BRPI0710131B1 (pt) 2020-03-10
HUE032804T2 (en) 2017-11-28
PT3246402T (pt) 2020-07-14
PL2010649T3 (pl) 2017-08-31
JP2013198497A (ja) 2013-10-03
EP3246402A1 (en) 2017-11-22
JP2009533033A (ja) 2009-09-17
JP6185617B2 (ja) 2017-08-23
HK1131633A1 (zh) 2010-01-29
KR101168623B1 (ko) 2012-08-03
CN101421396B (zh) 2016-01-20
KR20080106349A (ko) 2008-12-04
JP5683809B2 (ja) 2015-03-11
EP2010649A1 (en) 2009-01-07
CA2649135A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
PL3246402T3 (pl) Ulepszone mutanty rozpuszczalnej dehydrogenazy glukozowej zależnej od pirolochinolinochinonu
EP2241621A4 (en) MODIFIED GLUCOSE-DEHYDROGENASE GENE
PL2860179T3 (pl) Pochodne pirazolopirydyny jako inhibitory oksydazy NADPH
PL2139477T3 (pl) Pochodne pirazolopirydyny jako inhibitory oksydazy NADPH
PL2349261T3 (pl) Pochodne pirazolopirydyny jako inhibitory oksydazy NADPH
IL194975A0 (en) Composition and methods for treatment of congestive heart failure
AU2007207813A8 (en) EPSPS mutants
PL1935331T3 (pl) Proces przygotowania elektrod modyfikowanych, elektrod przygotowanych przy pomocy tego procesu i biosensory enzymatyczne zawierające takie elektrody
GB0719620D0 (en) Mutant Enzymes
ZA201005292B (en) Isolated alcohol dehydrogenase enzymes and uses thereof
PT1745136E (pt) Método para a preparação enzimática de ácido (s)-3-ciano-5-metil-hexanóico
EP1624071A3 (en) Method of detecting viable cells
PL2091530T3 (pl) Kompozycja hamująca aktywność oksydazy nadph
PL2201122T3 (pl) Enancjoselektywna enzymatyczna redukcja ketozwiązków
EP2079835A4 (en) COMPOSITIONS AND METHODS OF USE OF CHONDROITINASE ABCI MUTANTS
ZA200904235B (en) Method for the enantioselective enzymatic reduction of secodione derivatives
IL198286A0 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
EP1828252A4 (en) IMPROVED PROCESS FOR PREPARING HYDROXYALKYLCELLULOSE DERIVATIVES HAVING HIGH ENZYMATIC RESISTANCE
EP2205550A4 (en) FLUORINATED OXY CARBOXYLIC ACIDS, DERIVATIVES, AND METHODS OF PREPARATION
IL197189A0 (en) Methods of lowering glucose levels
HK1155746A (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AU2008901867A0 (en) Analyte extraction methods and extraction compositions
PL379557A1 (pl) Sposób otrzymywania preparatu enzymów
PL379558A1 (pl) Sposób otrzymywania preparatu enzymów
GB0605530D0 (en) Method and uses of compunds